Search

everythinglearnresearchcommunity

for

Search:↓

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

A thorough skin history and full examination are important for diagnosing and understanding the impact of skin diseases.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Follicular porokeratosis may be linked to diabetes and can lead to hair loss.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document is a detailed medical reference on skin and genetic disorders.

The study concluded that tick infestation was the most common skin problem in hospitalized dogs in Chennai, with various treatments used for different conditions.

Athletes need effective management of skin disorders for their performance and well-being.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that scalp conditions have various causes and can present in many different ways.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The document lists various dermatology topics, treatments, and diagnostic methods.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Dermoscopy helps diagnose different hair loss conditions, and characteristics vary among ethnicities and individual cases.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.